Aspire Biopharma faces potential Nasdaq delisting after compliance shortfall
Chief Operating Officer of Box Inc (NYSE:BOX), Olivia Nottebohm, sold 4,612 shares of Class A Common Stock on October 10, 2025, at a price of $33.1, totaling $152657. Box, currently valued at $4.7 billion, maintains impressive gross profit margins of 79% and demonstrates good financial health according to InvestingPro analysis.
According to a Form 4 filing with the Securities and Exchange Commission, the transaction reduced Nottebohm’s direct ownership to 506863 shares following the transaction.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on July 9, 2025.
In other recent news, Boxlight Corporation announced that it has regained compliance with Nasdaq Capital Market listing standards, as confirmed by a recent SEC filing. This development follows the company’s efforts to meet requirements related to minimum stockholders’ equity, independent directors, and audit committee composition. Additionally, Boxlight has appointed Cherry Bekaert LLP as its new auditor, replacing Forvis Mazars, LLP. The previous auditor’s reports did not contain any adverse opinions but expressed doubt about Boxlight’s ability to continue as a going concern.
Meanwhile, Box Inc. has seen mixed reactions from analysts. UBS downgraded Box Inc.’s stock rating from Buy to Neutral, citing limited near-term upside and adjusting its price target to $36.00. In contrast, DA Davidson reiterated its Buy rating for Box Inc., maintaining a $45.00 price target, expressing optimism about the company’s growth prospects following new product announcements at the BoxWorks 2025 virtual event. UBS also maintained a Buy rating and a $42.00 price target after the BoxWorks conference, highlighting several new generative AI product announcements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.